QIAGEN has presented its new high-throughput sample processing system at SLAS2026. The QIAsprint Connect marks the company’s entry into high-throughput sample processing, enabling preparation of up to 192 samples per run while reducing plastic consumption. QIAGEN hopes the system can address demand for automation and throughput in applications,… Read More
Life sciences company Parse Biosciences has partnered with research institute Graph Therapeutics to create what it says is one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will leverage Graph’s lab-in-the-loop platform with Parse’s GigLab to profile hundreds of millions of cells from patients with immune diseases… Read More
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich has announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyse an ambitious future phase to… Read More
